Stay updated on Belantamab vs Bortezomib in MM Clinical Trial

Sign up to get notified when there's something new on the Belantamab vs Bortezomib in MM Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Belantamab vs Bortezomib in MM Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    Added a note indicating NIH funding (2018 U.S. NIH Grant/Contract) and updated the study record revision to v3.6.6, replacing v3.6.5.
    Difference
    0.1%
    Check dated 2026-08-30T22:01:30.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    The page adds related topic links for Multiple myeloma and MedlinePlus Genetics to connect users with genetics information relevant to the disease.
    Difference
    0.1%
    Check dated 2026-08-23T18:53:02.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    The page's content no longer includes the term 'Multiple myeloma' in the conditions and related topics sections and removes the 'MedlinePlus Genetics' reference. This changes how the study is described and how related educational resources are linked.
    Difference
    0.1%
    Check dated 2026-08-16T15:37:44.000Z thumbnail image
  4. Check
    26 days ago
    Change Detected
    Summary
    The page now includes a 'Multiple myeloma' topic tag and expands the related topics to include 'MedlinePlus Genetics'. The revision stamp was updated from v3.6.4 to v3.6.5.
    Difference
    0.1%
    Check dated 2026-08-09T11:00:15.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    Revision: v3.6.4 is now shown, replacing v3.6.3. This reflects a platform release update and does not modify the study content.
    Difference
    0.0%
    Check dated 2026-07-25T16:59:11.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    The page no longer displays the 'Multiple myeloma' disease label, the 'related topics:' header, and the MedlinePlus Genetics link. This reduces visible disease context and related resource references for users.
    Difference
    0.1%
    Check dated 2026-07-18T14:42:26.000Z thumbnail image

Stay in the know with updates to Belantamab vs Bortezomib in MM Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Belantamab vs Bortezomib in MM Clinical Trial page.